High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases: a monocentric retrospective cohort study.
M BertlichI BertlichN PlümacherE HadaschikA EnkJochen H O HoffmannPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)